申请人:AYDT Ewald M.
公开号:US20110142765A1
公开(公告)日:2011-06-16
Pharmaceutical compositions comprising at least one compound of the formula (I) and a pharmaceutically acceptable carrier which is useful in a medicine wherein the symbols and substituents have the following meaning —X— is e.g. and Y being e.g. or the pharmaceutically acceptable salts, esters or amides and prodrugs can be applied to modulate the in-vitro and in-vivo binding processes mediated by E-, P- or selectin binding.
制药组合物包括至少一种式(I)化合物和药学上可接受的载体,其在药学上有用,其中符号和取代基具有以下含义:-X-例如,并且Y例如或药学上可接受的盐,酯或酰胺和前药可以应用于调节由E-,P-或选择素结合介导的体外和体内结合过程。